Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial

Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use

A.Y. Finlay, Ghazala Khan · Clinical and Experimental Dermatology · 1994 · 5.5K citations

Medicine, Dermatology, Allergy +8

Nonparametrics: Statistical Methods Based on Ranks

Mitchell J. Mergenthaler, E. L. Lehmann · Technometrics · 1979 · 3.4K citations

Natural Sciences, Biostatistics, Experimental Design +11

Nonparametrics: Statistical Methods Based on Ranks.

Robert J. Beaver, E. L. Lehmann · Biometrics · 1976 · 2.1K citations

Natural Sciences, Biostatistics, Statistics +9

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

Kristian Reich, Frank O. Nestlé, Kim Papp et al. · The Lancet · 2005 · 1K citations

Medicine, Dermatology, Pharmacotherapy +12

Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity <i>in vitro</i> and in a model of psoriasis

PH Schafer, Andrew Parton, Lori Capone et al. · British Journal of Pharmacology · 2009 · 404 citations · Full text

Medicine, Immunology, Pharmacology +17